Eye (Lond) 33(3):478485 Daniels AB et al (2007) Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)
This article is part of the PlexusDx Education Hub practical, evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic factors behind every metabolic decision
Navigating whether insurance will cover your weight loss medication can be daunting, but we simplify this process
Legal Important Safety Information Last modified: April 10, 2026 Semaglutide (Compounded) Compounded semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used under the supervision of a licensed provider to support weight management in adult women who meet medical eligibility criteria
Most people experienced no issue after taking the injections, but side effects are possible, particularly if the administration isnt handled by a certified professional
2-4 the risk for experiencing the more seriously complications seems to be associated with longer-term use of the medications